TolaSure Topical Gel

DRUG3 trials

Sponsors

BioMendics, LLC

Conditions

Epidermolysis Bullosa SimplexWound Healing

Phase 1

Safety and Efficacy of Topical TolaSure on Skin Punch Biopsies in Healthy Participants

CompletedNCT03620175

BioMendics, LLCWound Healing

Start: 2018-07-16End: 2018-12-12Updated: 2019-01-30

Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex

CompletedNCT05062070

BioMendics, LLCEpidermolysis Bullosa Simplex

Start: 2022-05-05End: 2023-06-22Updated: 2023-09-11

Phase 2

Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants

CompletedNCT04088357

BioMendics, LLCWound Healing

Start: 2019-08-26End: 2020-04-22Updated: 2021-06-24